Patent · US Active

Method for diagnosing an increased risk of preeclampsia by measuring the level of HIF-α

US8007769B2 · kind B2 · utility

0Cited by

3References

22Claims

0Family size

Assignee

MOUNT SINAI HOSPITAL · CA

Inventors

Isabella Caniggia · Toronto, CA
Martin Post · Amsterdam, NL
Stephen Lye · Toronto, CA

Key dates

Filing date	May 21, 2010
Grant date	Aug 30, 2011
Priority date	—
Expiry date	May 21, 2030

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/368
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Methods are provided for the diagnosis and treatment of patients with increased risk of preeclampsia. The methods involve measuring levels of TGF-β3, receptors of cytokines of the TGβ family, or HIF-1α.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.